iSonea Limited

iSonea Ltd (ASX:ISN; OTCQX:ISOAY) is developing innovative, non-invasive devices and mobile health applications using Acoustic Respiratory Monitoring (ARM™), to improve the management of costly, chronic respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). By combining this proprietary technology with its AsthmaSense™ mobile apps and universally available smartphones, iSonea enables anyone, anywhere, at any time to monitor breathing distress symptoms, in order to take action and improve personal outcomes. iSonea's core ARM™ technology has produced 3 devices that have received clearance from the U.S. FDA, the European Union CE, and the Australian TGA.

• Employees1
• Founded2006